Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Albumin versus mannitol versus saline for fluid distribution during hemodialysis
MOH_2021-07-02_010107Phase 3Recruiting
- Sponsor
- דר' קרן דואניס
- Start
- Mar 2021
- Modality
- Recombinant Proteins and Enzymes, Small Molecules, Inhalation Devices → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of albumin (human), Bronchitol and saline in chronic kidney disease (CKD) (3 arms), sponsored by דר' קרן דואניס. Primary endpoints: Fluid distribution and Hemodynamic stability. Started Mar 2021; status: recruiting.
02
Drugs
albumin (human)Bronchitolsaline
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on MOH_2021-07-02_010107.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2021-07-02_010107.